Home » Nucleic Acid Quantitation » iQuant™ dsDNA HS Assay Kit

 

iQuant™ dsDNA HS Assay Kit

Introduction

The iQuant™ dsDNA HS Assay Kit is designed specifically for an easy and accurate quantitation of dsDNA. The kit is highly selective for dsDNA over RNA, and offers advantages in stability, linear dynamic range, and sensitivity over other traditional methods of DNA quantitation. The kit contains concentrated quantitation reagent, dilution buffer, and pre-diluted dsDNA standards. Simply dilute the reagent using the buffer provided, add your sample (any volume between 1 µl and 20 µl is acceptable), and read the fluorescence using a fluorescence plate reader or fluorometer (Figure 1). The assay is well tolerated to common contaminants such as proteins, salts, solvents, detergents, or free nucleotides. The assay can be adapted for use in microplates, tubes or cuvettes.
 

Figure 1. Left: Quantitation of dsDNA with iQuant™ dsDNA HS Assay Kit using fluorescence plate reader. Right: Quantitation of dsDNA with iQuant™ dsDNA HS Assay Kit using Qubit® Fluorometer.

 

Specifications:

Sample Type: dsDNA
Platform: Fluorescence plate reader or fluorometer
Linear Range: 0.2-100 ng dsDNA

 

Applications

dsDNA quatitation in solution (Figure 2).

Figure 2. iQuant™ dsDNA HS assay workflow

To Order

Buy Cat. No. Product Name Sensitivity Unit Price
N010 iQuant™ dsDNA HS Assay Kit 0.2-100 ng 200 assays $65
N011 1,000 assays $200

Documents

 

Protocol (PDF): N010 N011
MSDS (PDF):  MSDS-N010 MSDS-N011
COA (PDF): COA-N010 COA-N011


Cited Reference:

Efficacy of siRNA-loaded nanoparticles in the treatment of K-RAS mutant lung cancer in vitro
Ayse Gencer, Ipek Baysal, Emirhan Nemutlu, Samiye Yabanoglu-Ciftci & Betul Arica
Journal of Microencapsulation, 2022, 39:3, 261-275, DOI: 10.1080/02652048.2022.2061058


Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins
Sahin, E., Bozdayi, G., Yigit, S., Muftah, H., Dizbay, M., Tunccan, O. G., … Caglar, K.
Journal of Medical Virology, 93(10), 6016–6026. doi:10.1002/jmv.27188


Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
Rein, M., Ben-Yacov, O., Godneva, A. et al.
BMC Med 20, 56 (2022). https://doi.org/10.1186/s12916-022-02254-y


Personalized Postprandial Glucose Response–Targeting Diet Versus Mediterranean Diet for Glycemic Control in Prediabetes
Orly Ben-Yacov, Anastasia Godneva, Michal Rein, Smadar Shilo, Dmitry Kolobkov, Netta Koren, Noa Cohen Dolev, Tamara Travinsky Shmul, Bat Chen Wolf, Noa Kosower, Keren Sagiv, Maya Lotan-Pompan, Niv Zmora, Adina Weinberger, Eran Elinav, Eran Segal
Diabetes Care 1 September 2021; 44 (9): 1980–1991. https://doi.org/10.2337/dc21-0162


Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease
Sery, O., Zeman, T., Sheardová, K. et al.
Sci Rep 12, 10994 (2022). https://doi.org/10.1038/s41598-022-15299-z